Physician profile
Robert Bryant Mclafferty
NPI 1295721728
$15,315.76
in general payments reported to CMS, 2019-2025
23 companies · $668 in 2025
The $668 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,570 · 2020: $4,476 · 2021: $3,709 · 2022: $1,518 · 2023: $1,332 · 2024: $1,044 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,344 · Consulting Fee: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,343.66 |
| Consulting Fee | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,975.90 | 2019-2023 | Varithena Administration Pack |
| Convatec INC. | $3,025.00 | 2021 | |
| Endologix LLC | $1,400.00 | 2022-2023 | Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $1,375.32 | 2022-2025 | Venaseal, Endurant Iis |
| Medtronic Vascular, INC. | $426.63 | 2019-2020 | |
| Penumbra, INC. | $281.19 | 2024-2025 | Indigo System |
| Cook Medical LLC | $265.56 | 2022-2023 | Zilver Vena |
| Bard Peripheral Vascular, INC. | $239.05 | 2019-2022 | |
| Tactile Systems Technology INC | $188.50 | 2019 | |
| Integra Lifesciences Corporation | $175.00 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Inspiremd LTD | $168.00 | 2024 | Cguard |
| Inari Medical, INC. | $162.49 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $131.16 | 2022-2024 | Esprit |
| Mimedx Group, INC. | $102.79 | 2024 | |
| Amniox Medical, INC. | $76.70 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $76.64 | 2025 | Restrata Wound Matrix |
| Abbvie INC. | $70.00 | 2024 | |
| Arthrex, INC. | $37.00 | 2023 | |
| Teleflex LLC | $35.94 | 2024 | Manta |
| Reapplix INC. | $34.85 | 2022 | |
| Biotissue Holdings INC. | $28.65 | 2019 | |
| Kerecis Limited | $26.40 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mclafferty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.